By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Gilead Sciences, Inc. 

333 Lakeside Drive

Foster City  California  94404  U.S.A.
Phone: 800-GILEAD-5 or 650-574-3000 Fax: 650-522-5800


SEARCH JOBS


Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need.The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.


Key Statistics


Email:
Ownership: Public

Web Site: Gilead
Employees: 4,000
Symbol: GILD
 



Industry
Biotechnology






Company News
Gilead (GILD) Submits New Drug Application To U.S. FDA For Single Tablet Regimen For HIV Containing Rilpivirine, Emtricitabine And Tenofovir Alafenamide (R/F/TAF) 7/2/2015 9:48:49 AM
Two Yale University Health Info Groups Sue FDA, Gilead (GILD) for Hep C Drug Trial Data 6/30/2015 6:29:23 AM
China Rejects Patent Linked To Gilead (GILD) Hepatitis C Drug 6/22/2015 7:07:52 AM
The Medicines Patent Pool And Gilead (GILD) Expand Licence To Allow Generic Manufacture Of Medicines In South Africa 6/11/2015 6:56:19 AM
Receptos (RCPT) Allegedly Rebuffs AstraZeneca PLC (AZN) Bid But Rivals Gilead (GILD), Teva (TEVA) are Circling 6/10/2015 5:56:54 AM
Gilead (GILD) To Present At Two Upcoming Investor Conferences On Tuesday, June 9 6/9/2015 11:01:09 AM
Express Scripts Exec's Elaborate Scheme to Load Up a Cruise Ship in India With Cheap Versions of Gilead (GILD) Sovaldi 6/3/2015 8:01:12 AM
Gilead (GILD) Release: Zydelig In Combination With Ofatumumab Improves Progression-Free Survival In Previously-Treated Patients With Chronic Lymphocytic Leukemia 6/1/2015 11:39:43 AM
Gilead (GILD) To Present At The Bernstein 31st Annual Strategic Decisions Conference On Thursday, May 28 5/28/2015 10:49:34 AM
European Medicines Agency Validates Gilead (GILD)’s Marketing Application For Fixed-Dose Combination Of Emtricitabine And Tenofovir Alafenamide For HIV Treatment 5/28/2015 10:47:35 AM
12345678910...
//-->